Charles E. and Susan T. Harris Professor, MIT Sloan School of Management; Director, MIT Laboratory for Financial Engineering

READ MORE >

Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs

New estimates offer guidance to biopharma investors and policymakers seeking to identify areas most likely to be underserved by private sector engagement and in need of public sector support.

READ MORE >

Teaching: No Longer Just For The Classroom

In addition to lecturing for the students at MIT, technology is taking Andrew’s classes off-campus and across the globe.

READ MORE >

Bayesian Adaptive Clinical Trials for Anti-Infective Therapeutics During Epidemic Outbreaks

New research illustrate the importance of adapting the clinical trial design and the regulatory approval process to the specific parameters and stage of the epidemic.

READ MORE >

Advising the Next Generation

See Andrew’s students, current and former, who have and will go on to be leaders in their respective industries.

READ MORE >

Spectral Factor Models

Recent research shows that traditional factor models restriction of spectral betas can hide horizon-specific pricing effects which spectral factor models are designed to reveal.

READ MORE >

Will a Covid-19 Vaccine Change the Future of Medical Research?

Andrew recently joined Freakonomics Radio to discuss Covid-19 may finally change how diseases are cured.

READ MORE >

Recent Publications

Robert C. Merton: The First Financial Engineer
Competition and R&D Financing: Evidence from the Biopharmaceutical Industry
Algorithmic Models of Investor Behavior
Real-time Extended Psychophysiological Analysis of Financial Risk Processing
The Wisdom of Crowds Versus the Madness of Mobs: An Evolutionary Model of Bias, Polarization, and Other Challenges to Collective Intelligence
To Maximize or Randomize? An Experimental Study of Probability Matching in Financial Decision Making
How does news affect biopharma stock prices?: An event study
Life sciences intellectual property licensing at the Massachusetts Institute of Technology
Parkinson’s Patients’ Tolerance for Risk and Willingness to Wait for Potential Benefits of Novel Neurostimulation Devices: A Patient-Centered Threshold Technique Study
Funding Long Shots
Quantifying the Impact of Impact Investing